Impact of Seasonal Malaria Chemoprevention in Children 5 to 10 Years in Kita and Bafoulabe Districts, Mali.
Abstract Background : Seasonal malaria chemoprevention (SMC) is the administration of complete therapeutic courses of antimalarial to all children 3–59 months old during the malaria transmission season. This study measured coverage, impact and cost of adding SMC in children aged 5-10 years. Methods : A non-randomized, pre-post design, with an intervention (Kita) and control (Bafoulabe) district implemented SMC for children 5-10 years old through the health system in 2017 and 2018. SMC implementation consisted of the administration of SP + AQ at monthly intervals in children 5-10 years in July, August, September and October annually. Baseline and endline household surveys were conducted in both districts. Separate surveys to measure adherence and tolerance to treatment occurred annually in the intervention district (200 households) following each of the four treatment rounds. Routine data on malaria cases tested and treated and information on SMC campaign and treatment costs were collected. Results : A total of 310 and 323 children 5 to 10 years were included in Kita and Bafoulabe respectively in the baseline survey in July 2017, plasmodium infection prevalence was comparable in the two districts (p=0.07): 27.7% in the intervention district (Kita) against 21.7% in the comparison district (Bafoulabé). Mild anemia was found in 14.2% of children in Kita vs 10.5% in Bafoulabé. Household survey found 89.1% of SMC coverage rate, child’s mothers were interviewed with 93.3% during the SMC campaign in Kita. The most side effect reported by parents was vomiting with 9.3%. One year after SMC implementation in 5 to 10 years in Kita, three doses coverage was 81.2%, there was a reduction by 40% (OR=0.60, CI:0.41-0.89) of malaria parasite carriage; 21% and 62% reduction of simple malaria and severe malaria prevalence respectively in the pilot district vs control. Mild anemia and severe anemia were comparable in the two districts. The level of malaria molecular resistance rate remains below the threshold. Quintuple mutation (dhfr triple +dhps437+dhps540) remained <5% after intervention in both districts.Conclusion: The SMC strategy contributed to malaria prevention in 5-10 year old children and should be integrated to SMC for children 3-59 months. Keywords : Malaria, Seasonal Malaria Chemoprevention, Sulfadoxine-Pyriméthamine, Amodiaquine, Anemia.